Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: evidence for immunopathogenesis

R P Lisak

    Neurology
    |July 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Evidence suggests immune system dysfunction plays a role in multiple sclerosis (MS) pathogenesis. However, the specific immune reactions and targets in MS remain unclear, as do the causes of immune control abnormalities.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunologic characterization of oligodendroglia.

    Neuroscience letters·2009
    Same author

    Predictors of well-being among significant others of persons with multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2007
    Same author

    A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2006
    Same author

    Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2006
    Same author

    Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data.

    Acta neurologica Scandinavica·2004
    Same author

    Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2003
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Area of Science:

    • Neuroimmunology
    • Pathology of Multiple Sclerosis

    Background:

    • Multiple sclerosis (MS) is a chronic neurological disease characterized by clinical and pathological findings.
    • The underlying causes of MS are not fully understood, but immune system involvement is suspected.

    Purpose of the Study:

    • To review the existing evidence for immunopathologic mechanisms in multiple sclerosis (MS).
    • To identify the types of immune reactions and their targets involved in MS.
    • To examine abnormalities in immunologic control mechanisms in MS patients.

    Main Methods:

    • Literature review of studies investigating the immunopathogenesis of multiple sclerosis (MS).
    • Analysis of evidence for various immunologic reactions and potential antigens (autoantigens, neoantigens, microbial antigens).

    Related Experiment Videos

  • Evaluation of data on immune control mechanisms in individuals with MS.

    • Main Results:

    • Considerable evidence supports an immune system role in the pathogenesis of multiple sclerosis (MS).
    • The specific types of immune reactions and their targets in MS are not clearly defined.
    • Abnormalities in immune control mechanisms are observed in MS patients, but their causal role is uncertain.

    Conclusions:

    • The immunopathogenesis of multiple sclerosis (MS) is supported by substantial evidence.
    • Further research is needed to elucidate the precise immune mechanisms and targets in MS.
    • The relationship between immune control abnormalities and MS development requires clarification.